
Read this post, part of a six-part series, for commentary on the issues surrounding drug industry support of non-profit organizations.
« Classic Post 1: As Observers Criticize Johnson & Johnson For Suing The Red Cross, Corporate Blog Could Play Valuable Role | Main | Classic Post 3: British Cyberchondriacs Skip Canned Content & Ads, Favor Personal Stories »
|
Jan 2
|
![]()
Read this post, part of a six-part series, for commentary on the issues surrounding drug industry support of non-profit organizations.
|
TrackBack URL for this entry:
« Classic Post 1: As Observers Criticize Johnson & Johnson For Suing The Red Cross, Corporate Blog Could Play Valuable Role | Main | Classic Post 3: British Cyberchondriacs Skip Canned Content & Ads, Favor Personal Stories »
Comment Preview